These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7727179)
41. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty. van den Brand M; van Zijl A; Geuskens R; de Feyter PJ; Serruys PW; Simoons ML Eur Heart J; 1991 Nov; 12(11):1208-14. PubMed ID: 1782951 [TBL] [Abstract][Full Text] [Related]
42. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581 [TBL] [Abstract][Full Text] [Related]
43. Immediate and long term results of percutaneous coronary angioplasty in patients aged 70 and over. de Jaegere P; de Feyter P; van Domburg R; Suryapranata H; van den Brand M; Serruys PW Br Heart J; 1992 Feb; 67(2):138-43. PubMed ID: 1540433 [TBL] [Abstract][Full Text] [Related]
44. [Comparison of outcome of primary PTCA for acute myocardial infarction in patients younger and older than 70 years of age]. Santoro GM; Valenti R; Buonamici P; Cerisano G; Bolognese L; Antoniucci D; Fazzini PF G Ital Cardiol; 1996 Oct; 26(10):1111-22. PubMed ID: 9005157 [TBL] [Abstract][Full Text] [Related]
45. Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Råmunddal T; Hoebers LP; Henriques JP; Dworeck C; Angerås O; Odenstedt J; Ioanes D; Olivecrona G; Harnek J; Jensen U; Aasa M; Albertsson P; Wedel H; Omerovic E JACC Cardiovasc Interv; 2016 Aug; 9(15):1535-44. PubMed ID: 27491603 [TBL] [Abstract][Full Text] [Related]
47. Outcome of percutaneous coronary intervention in unstable angina pectoris versus stable angina pectoris in two different time periods. Naidu SS; Polin GM; Selzer F; Laskey WK; Jacobs AK; Williams DO; Wilensky RL Am J Cardiol; 2006 Aug; 98(4):447-52. PubMed ID: 16893695 [TBL] [Abstract][Full Text] [Related]
48. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators. Dzavik V; Carere RG; Teo KK; Knudtson ML; Marquis JF; Buller CE Can J Cardiol; 1998 Jun; 14(6):825-32. PubMed ID: 9676168 [TBL] [Abstract][Full Text] [Related]
49. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393 [TBL] [Abstract][Full Text] [Related]
51. Aggressive pattern of angina after successful coronary angioplasty: the role of clinical and angiographic factors. Chen L; Leatham E; Chester M; Huang J; Kaski JC Eur Heart J; 1995 Aug; 16(8):1085-91. PubMed ID: 8665970 [TBL] [Abstract][Full Text] [Related]
52. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups. Hermans WR; Foley DP; Rensing BJ; Rutsch W; Heyndrickx GR; Danchin N; Mast G; Hanet C; Lablanche JM; Rafflenbeul W Am J Cardiol; 1993 Jul; 72(1):14-20. PubMed ID: 8517422 [TBL] [Abstract][Full Text] [Related]
53. Restenosis presented with unstable angina and myocardial infarction: one explanation for late cardiac events following directional coronary atherectomy. Hwang MH; Lewis BE; Hsieh A; Jones PA; Leya F; Loeb HS Cathet Cardiovasc Diagn; 1994 Nov; 33(3):234-6. PubMed ID: 7874717 [TBL] [Abstract][Full Text] [Related]
54. Short stature and prognosis of coronary heart disease in women. Wamala SP; Mittleman MA; Horsten M; Schenck-Gustafsson K; Orth-Gomér K J Intern Med; 1999 Jun; 245(6):557-63. PubMed ID: 10395184 [TBL] [Abstract][Full Text] [Related]
55. Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence. Lim R; Laskey WK J Am Coll Cardiol; 1997 Nov; 30(6):1461-5. PubMed ID: 9362402 [TBL] [Abstract][Full Text] [Related]
56. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Cowley MJ; Dorros G; Kelsey SF; Van Raden M; Detre KM Am J Cardiol; 1984 Jun; 53(12):12C-16C. PubMed ID: 6233874 [TBL] [Abstract][Full Text] [Related]
57. Predictors for waiting time for coronary angioplasty in a high risk population. Gaffney B; Kee F Qual Health Care; 1995 Dec; 4(4):244-9. PubMed ID: 10156393 [TBL] [Abstract][Full Text] [Related]
58. Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes. Sato T; Yoshinouchi T; Sugimoto T; Sakamoto T; Fujieda H; Murao S; Sato H; Ohe T Jpn Circ J; 1999 Aug; 63(8):583-8. PubMed ID: 10478806 [TBL] [Abstract][Full Text] [Related]
59. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease. Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964 [TBL] [Abstract][Full Text] [Related]